USE OF EMDOGAIN PROTEIN IN TREATMENT OF CHRONIC PERIODONTITIS

Apply

USE OF EMDOGAIN PROTEIN IN TREATMENT OF CHRONIC PERIODONTITIS

Journal Title: WORLD JOURNAL PHARMACY AND PHARMACEUTICAL SCIENCE - Year 2018, Vol 7, Issue 9

Abstract

This study evaluated the efficacy of Emdogain enamel matrix proteins as a regenerative material in interproximal vertical defects both clinically and radiographically. Patients aged 18 to 45 years and diagnosed with chronic or aggressive periodontitis were included. 32 intrabony defects in Sixteen patients were surgically treated using a split-mouth design. Emdogain placement was done at experimental sites. Since both chronic and aggressive periodontitis patients were included, an attempt was made to interpret results between the two types of cases. Post surgical measurements at 9 months revealed no significant difference in mean pocket depth reduction, clinical attachment level gain, amount of defect fill, or defect resolution between control and experimental groups. Mean pocket depth reduction and amount of defect fill were significant in both groups. The results were interpreted separately for chronic and aggressive periodontitis cases. This study demonstrated no added advantage of using Emdogain compared to surgical debridement alone. Further long-term and large-sample-size evaluation is required to prove Emdogain's consistent efficacy.

Authors and Affiliations

Sarab Hussien Khalaf

Keywords

This study evaluated the efficacy of Emdogain consistent efficacy.

EP ID EP627985
DOI -
Views 128
Downloads 0